Report
Cannabis stocks slump amid a procedural DEA delay
Barron's reports that Trulieve Cannabis stock fell after the DEA paused pending rescheduling proceedings in a case that could federally recognize cannabis for medical use.
TLDR
Barron's attributes a slump in cannabis stocks to a procedural DEA delay. It reports that Trulieve Cannabis stock fell after the agency paused pending rescheduling proceedings in a case that could federally recognize cannabis for medical use.
Combined views
3.6K
1 Source, first seen ago